Cingulate Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Cingulate Inc. on November 3, 2023, regarding a Special Meeting of Stockholders held on the same date. The Company is incorporated in Delaware and its securities trade on the Nasdaq Capital Market under the symbols CING (Common Stock) and CINGW (Warrants).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions and voting results.
Material Changes and Voting Results
Two proposals were submitted to and approved by stockholders at the Special Meeting:
- Proposal 1 (Reverse Stock Split): Stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split. The Board of Directors is authorized to determine a ratio between 1-for-2 and 1-for-40 at any time within one year of the meeting without further shareholder approval.
- Voting Results: 8,030,933 For; 1,887,420 Against; 26,158 Abstain; 0 Broker Non-Votes.
- Proposal 2 (Warrant Issuance Approval): Stockholders approved the issuance of up to 10,387,812 shares of common stock issuable upon the exercise of Series A and Series B warrants. This approval is required to comply with Nasdaq Listing Rule 5635(d) regarding warrants issued to an institutional investor in connection with an offering that closed on September 13, 2023.
- Voting Results: 9,068,789 For; 769,070 Against; 106,652 Abstain; 0 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, or specific risk factors beyond the context of the Nasdaq listing compliance for the warrant issuance.
Key Facts for Investor Verification
- Verify the exact reverse stock split ratio once determined by the Board of Directors, as the filing only authorizes a range (1:2 to 1:40).
- Confirm the status of the Series A and Series B warrants issued on September 13, 2023, and the potential dilution from the 10,387,812 shares approved for issuance.
- Monitor the Company's compliance with Nasdaq listing requirements following the implementation of the reverse stock split.